entertainment -WSS

entertainment

author：comprehensive 2025-09-30 01:12:44 - browse：2665

Adam's take main illustration — Molly Ferguson/STAT

This week, I address pushback I received on my Novartis-MorphoSys column. But first, a preview of the expected readout from Gritstone Bio’s neoantigen cancer vaccine study.

A looming test for neoantigen cancer vaccines

Before the end of the quarter, Gritstone Bio will release preliminary results from a randomized, Phase 2 clinical trial investigating a personalized therapeutic cancer vaccine in microsatellite-stable colon cancer, a type of “immunologically cold” tumor that is resistant to immunotherapies like PD-1/PD-L1 inhibitors.

The Gritstone vaccine is designed to train a patient’s own T cells to recognize and kill cancer cells by targeting mutated cancer proteins, called neoantigens, that are unique to a patient’s own tumor. It’s a relatively new approach for cancer vaccines — made possible by powerful and relatively inexpensive genomic sequencing of tumors – that is intended to overcome all the previous failures in the field. Gritstone’s effort is also similar to one being used by Moderna and Merck that has reported encouraging results in melanoma — and is now being investigated in a Phase 3 study.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Amylyx ALS drug fails large clinical trial

explore

WSS

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

What causes an itch? Researchers may have solved the mystery

Just how do doctors, lawmakers, and the public define abortion?

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

Amylyx ALS drug fails large clinical trial

Air quality improving but still lags in Black, Hispanic communities

entertainment

entertainment

A looming test for neoantigen cancer vaccines

focus

Moonlake's readout produced a cash windfall. Risks remain

Air quality improving but still lags in Black, Hispanic communities

The cancer drug shortage isn’t new — and neither are the solutions

SCOTUS to consider access to abortion pill mifepristone

Alkermes shareholders re

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

The Readout: Amylyx, Alumis, and Lundbeck drug updates

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

explore

STAT letters to the editor on burnt

SCOTUS to consider access to abortion pill mifepristone

What it’s like to watch children die of measles

Change Healthcare cyberattack prompts Medicare loan program

Leukemia patients are helped by Syndax's new type of therapy

CMS should re

knowledge

hotspot

explore

hotspot